Susquehanna International Group’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.4K | Buy |
27,606
+9,200
| +50% | +$10.1K | ﹤0.01% | 6108 |
|
|
2025
Q1 | $23K | Sell |
18,406
-16,075
| -47% | -$20.1K | ﹤0.01% | 6135 |
|
|
2024
Q4 | $53.4K | Sell |
34,481
-747
| -2% | -$1.16K | ﹤0.01% | 5851 |
|
|
2024
Q3 | $67.3K | Sell |
35,228
-19,606
| -36% | -$37.4K | ﹤0.01% | 5223 |
|
|
2024
Q2 | $107K | Buy |
54,834
+13,646
| +33% | +$26.7K | ﹤0.01% | 5073 |
|
|
2024
Q1 | $97.6K | Buy |
41,188
+19,160
| +87% | +$45.4K | ﹤0.01% | 5014 |
|
|
2023
Q4 | $47.6K | Buy |
+22,028
| New | +$47.6K | ﹤0.01% | 5552 |
|
|
2023
Q2 | – | Sell |
-106,886
| Closed | -$311K | – | 6282 |
|
|
2023
Q1 | $311K | Buy |
+106,886
| New | +$311K | ﹤0.01% | 4378 |
|
|
2022
Q4 | – | Sell |
-16,624
| Closed | -$40K | – | 6550 |
|
|
2022
Q3 | $40K | Sell |
16,624
-61,985
| -79% | -$149K | ﹤0.01% | 5565 |
|
|
2022
Q2 | $178K | Buy |
78,609
+50,547
| +180% | +$114K | ﹤0.01% | 4656 |
|
|
2022
Q1 | $65K | Buy |
+28,062
| New | +$65K | ﹤0.01% | 5249 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6305 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5900 |
|